AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments.
Trading
Dollar Falls as Crude Prices Decline and Stocks Gain
The dollar index (DXY00) fell by -0.32% on Friday. The dollar was under pressure Friday after WTI crude oil prices fell more than -2%, easing inflation expectations and weighing on Fed policy. Also, strength in stocks o…
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?
Novo Nordisk needs new products to better compete with Eli Lilly in the weight loss market.
Stock Market Today, Sept. 25: Tesla Stock Under Pressure Despite Plans to Ramp Semi Truck Production
Tesla (NASDAQ:TSLA), the global electric-vehicle, battery storage, and autonomous driving systems company, closed at $372.11, down 1.54%. Analyst cuts overshadowed plans for Tesla's Semi Truck production ramp. Trading v…
Dollar Weakness Spurs Short Covering in Coffee Futures
Coffee prices are climbing today, with arabica posting a 1-week high. Today’s slide in the dollar index ($DXY) has sparked fund short covering in coffee futures.
Wheat Falling Lower on Friday with Black Sea Pressure
Wheat is under pressure to start Friday, with the three exchanges down 12 to 20 cents. The wheat complex saw some pressure on Thursday. Chicago SRW saw losses of 1 ½ to 5 ¼ cents at the close. Open interest was down 2,6…
3 Steps to Avoid Running Out of Money in Retirement
Many pre-retirees worry that once they stop working and age, they'll face health issues, boredom, and social isolation. But there's one fear you can't ignore in the course of your retirement planning: running out of mon…
Crude Prices Slip in Hopes of Diplomacy Reopening the Strait of Hormuz
November WTI crude oil (CLX26) is down -0.58 (-0.61%) today, and November RBOB gasoline (RBX26) is down -0.0826 (-2.48%).
Top Retirement Fears -- and the Straightforward Fixes for Each
Given the state of the economy and geopolitical events beyond their control, it's no surprise that more Americans report feeling anxious about retirement. Among their top fears are healthcare costs and outliving their r…
Why Paychex Stock Slumped This Week
Paychex (NASDAQ: PAYX) may not be a household name for investors, but it is a closely watched company as an indicator of the strength in small and mid-sized businesses. Paychex provides payroll, human resources, and ben…
Stocks Finish Mostly Lower as Bond Yields Soar
The S&P 500 Index ($SPX) (SPY) closed down by -0.02% on Thursday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.31%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.03%. December E-mini S&P future…
CoreCivic Appoints Lucibeth Mayberry As CEO
(RTTNews) - CoreCivic, Inc. (CXW), a corrections and detention services provider, Friday said it has appointed Lucibeth N. Mayberry as president and chief executive officer.
AllianceBernstein Appoints Onur Erzan To Succeed Seth Bernstein As President & CEO
(RTTNews) - AllianceBernstein Holding L.P. (AB) and AllianceBernstein L.P. or AB, an investment management firm and a subsidiary of Equitable Holdings, Inc. (EQH), announced Friday the appointment of President Onur Erza…
The Stock Market Is Triggering a Warning Seen Only Once Before, and Warren Buffett Has a Stark Warning for Investors
The last few years have been lucrative for the stock market, with the S&P 500 (SNPINDEX: ^GSPC), Nasdaq Composite (NASDAQINDEX: ^IXIC), and Dow Jones Industrial Average (DJINDICES: ^DJI) all notching multiple record hig…
AstraZeneca's IMFINZI-Enfortumab Regimen Wins FDA Priority Review In Bladder Cancer
(RTTNews) - AstraZeneca plc (AZN) announced that the U.S. FDA has accepted and granted Priority Review to its supplemental Biologics License Application for IMFINZI in combination with enfortumab vedotin (EV) for the tr…
Wall Street Targets To Bounce Back To Positive Territory
(RTTNews) - Oil prices soared to above $116 a barrel on Friday, after President Trump revealed his plans to seize Iran's Kharg Island that handles 90 percent of Iran's oil export. Iran has been threatening of rain fire …
Fate Therapeutics Receives $15M CIRM Grant To Advance FT819 In Lupus Nephritis
(RTTNews) - Fate Therapeutics, Inc. (FATE), a clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies, announced that the California Institute for Regenerative Medicine (CIRM) awarded t…
Robinhood's Fastest-Growing Business Isn't Trading Stocks
Event contracts brought in $156 million of second-quarter revenue -- more than 10 times what the line produced a year earlier.
There's a New Threat to the Stock Market and President Donald Trump's Economy
The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite have consistently generated outsize returns under President Trump.
Nvidia Raised Its Dividend 2,400%, but a $10,000 Investment Still Pays Just $44 a Year
The majority of the company's capital-return program is allocated toward share buybacks, which have totaled nearly $40 billion this year.
Will the Nasdaq Fall After the First Interest Rate Hike in 3 Years? History Offers a Strikingly Clear Answer.
Less than a year ago, the Federal Reserve continued along a path that began in 2024. The central bank was in the middle of a series of interest rate cuts, something that is generally seen as supportive of consumers and …
$1,000 Invested in Micron Before Sept. 30 Could Be Worth This Much by 2028
Micron Technology (NASDAQ: MU) has a major event coming up in a few days: its Q4 earnings for the fiscal year (FY) 2026. The last few times Micron has reported, it has announced some incredible results, and I expect thi…
Social Security's 2027 COLA Could Well Outpace This Year's Raise. Here's How Helpful It Might Actually Be.
Current estimates point to a more generous Social Security COLA in the new year than this year's 2.8% increase.
Is SpaceX Stock a Buy, Sell, or Hold Right Now? Here's What I'm Doing.
Space Exploration Technologies (NASDAQ: SPCX) is one of the more interesting stocks on the market. While it went public with a lot of fanfare, some investors are still skittish about whether it's a good investment. Furt…